News Articles Tagged: Prostate Cancer Therapeutics

The Role of ODM-201 in Overcoming AR Resistance in Prostate Cancer

Explore how ODM-201 (CAS 1297538-32-9) targets AR mutations and resistance mechanisms, offering a new therapeutic avenue for advanced prostate cancer patients. Inquire about our supply.

Understanding ODM-201: A Next-Gen AR Inhibitor for Prostate Cancer

Discover ODM-201, a potent androgen receptor inhibitor. Learn about its advantages in treating castration-resistant prostate cancer and why it's a key pharmaceutical intermediate. Get pricing information.

The Importance of Abiraterone Acetate in Castration-Resistant Prostate Cancer (CRPC)

Discover the critical role of Abiraterone Acetate (CAS 154229-18-2) in managing CRPC. Learn about its benefits and why sourcing from NINGBO INNO PHARMCHEM CO.,LTD. is advantageous.

Exploring the Multifaceted Applications of Cardiogen Peptide: From Cardiac Health to Cancer Research

Discover the diverse research applications of Cardiogen peptide, including its impact on cardiac function, prostate health, and potential in cancer studies. Insights from NINGBO INNO PHARMCHEM CO.,LTD.